β-Blocker Efficacy in High-Risk Patients with the Congenital Long-QT Syndrome Types 1 and 2: Implications for Patient Management

BACKGROUND: β-blockers are the mainstay therapy in patients with the congenital long-QT syndrome (LQTS) types 1 and 2. However, limited data exist regarding the efficacy and limitations of this form of medical management within high-risk subsets of these populations. METHODS AND RESULTS: Multivariat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Goldenberg, Ilan, Bradley, James, Moss, Arthur, McNitt, Scott, Polonsky, Slava, Robinson, Jennifer L., Andrews, Mark, Zareba, Wojciech
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4005824/
https://ncbi.nlm.nih.gov/pubmed/20233272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1540-8167.2010.01737.x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares